NutraMax repurchasing 47% of its outstanding stock from Mediq.
This article was originally published in The Tan Sheet
Executive Summary
NUTRAMAX BUYBACK OF 47% OF OUTSTANDING STOCK FROM MEDIQ for $9 a share was announced by the private label company Sept. 9. The repurchase agreement "concludes a comprehensive process that began more than one year ago, and will eliminate the overhang in the stock created by" ownership by the medical equipment supplier, NutraMax President and CEO Donald Lepone said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning